Related Experiment Video
Updated: Aug 5, 2026
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Outcomes and Risk Factors in Young Patients with Head-and-Neck Cancer: A Multi-Center Retrospective Analysis
Fabian Baier1, Leila Erpenstein1, Julia Maurer2
1Klinik und Poliklinik für Strahlentherapie, Universitätsklinikum Regensburg, 93053 Regensburg, Germany.
Medicina (Kaunas, Lithuania)
|July 28, 2026
Summary
Young head and neck cancer (HNC) patients
Area of Science:
- Oncology
- Radiation Oncology
- Head and Neck Surgery
Background:
- Head and neck cancer (HNC) in patients ≤ 40 years is rare and poorly understood.
- Prognosis and risk factors for young HNC patients are debated.
- This study investigates outcomes and prognostic factors in young HNC patients treated with radiotherapy.
Purpose of the Study:
- To evaluate oncological outcomes in patients aged 40 years or younger with head and neck cancer.
- To identify independent prognostic factors influencing survival in this specific demographic.
- To analyze the impact of radio(chemo)therapy on overall survival (OS) and progression-free survival (PFS).
Main Methods:
- Retrospective multi-center analysis of 88 patients aged ≤ 40 years with histologically confirmed HNC.
- Patients received definitive or adjuvant radio(chemo)therapy between 2002 and 2023.
- Overall survival (OS) and progression-free survival (PFS) analyzed using Kaplan-Meier and Cox regression.
Main Results:
- Nicotine abuse, comorbidities, lack of complete remission post-radiotherapy, and recurrence/metastasis predicted OS.
- Failure to achieve complete remission was the sole predictor of PFS.
- Median OS differed significantly between adjuvant (91.0 months) and definitive (23.7 months) treatment groups.
Conclusions:
- Early treatment response and disease recurrence are key determinants of survival in young HNC patients.
- Modifiable lifestyle factors (e.g., nicotine abuse) and comorbidities impact outcomes.
- Intensified response monitoring and tailored follow-up are crucial for this population.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...